🇺🇸 FDA
Patent

US 10364275

Methods for treating inflammatory responses or diseases caused by inflammation using ApoA-I binding protein (APOA1BP)

granted A61KA61K38/00A61K38/1709

Quick answer

US patent 10364275 (Methods for treating inflammatory responses or diseases caused by inflammation using ApoA-I binding protein (APOA1BP)) held by The Regents of the University of California expires Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jul 30 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 25 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/00, A61K38/1709, A61K38/1761, A61P